List of BSI CTMS Customers
Baden, CH-5405,
Switzerland
Since 2010, our global team of researchers has been studying BSI CTMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased BSI CTMS for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using BSI CTMS for Clinical Trial Management include: Actelion Pharmaceuticals Ltd, a Switzerland based Life Sciences organisation with 2624 employees and revenues of $2.49 billion, Alk Abello, a Denmark based Life Sciences organisation with 2736 employees and revenues of $841.0 million, Dokumeds, a Latvia based Life Sciences organisation with 100 employees and revenues of $20.0 million and many others.
Contact us if you need a completed and verified list of companies using BSI CTMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the ERP Services and Operations software purchases.
The BSI CTMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of ERP Services and Operations software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Actelion Pharmaceuticals Ltd | Life Sciences | 2624 | $2.5B | Switzerland | BSI Business Systems Integration | BSI CTMS | Clinical Trial Management | 2006 | n/a |
In 2006 Actelion Pharmaceuticals Ltd and BSI Business Systems Integration signed an agreement to co-develop a new clinical trial system. One year later Actelion put the first version of BSI CTMS into operation for its clinical development organization.
The BSI CTMS implementation delivered core Clinical Trial Management capabilities, including study and protocol setup, site and investigator management, subject enrollment tracking, visit scheduling and monitoring workflows, and centralized trial document and regulatory tracking. Configuration work emphasized standard clinical operational workflows and role based access controls for study teams, aligning the application with common Clinical Trial Management functional modules.
The engagement followed a co-development and phased rollout model between Actelion Pharmaceuticals Ltd and BSI Business Systems Integration, moving from joint development to production use within a one year period. Governance focused on integrating BSI CTMS functionality into Actelion clinical operations and trial governance processes, with operational ownership assigned to Actelion’s clinical development teams.
|
 |
Alk Abello | Life Sciences | 2736 | $841M | Denmark | BSI Business Systems Integration | BSI CTMS | Clinical Trial Management | 2016 | n/a |
In 2016, Alk Abello implemented BSI CTMS to support clinical trial planning and management. The deployment targeted clinical development and clinical operations teams at Alk Abello, the specialist for allergy therapy headquartered in Hørsholm, Denmark, establishing BSI CTMS as the central Clinical Trial Management application for study lifecycle workflows.
The implementation emphasized core Clinical Trial Management capabilities common to the category, including study startup and planning, site and investigator management, subject tracking, regulatory and document management, and budgeting and milestone tracking. Governance and workflow changes centralized trial planning and operational oversight within the CTMS to standardize study governance and reporting across clinical functions.
|
 |
Dokumeds | Life Sciences | 100 | $20M | Latvia | BSI Business Systems Integration | BSI CTMS | Clinical Trial Management | 2016 | n/a |
In 2016, Dokumeds implemented BSI CTMS, a Clinical Trial Management application. The deployment centralized clinical trial operations for the 100-employee Latvia-based life sciences company, aligning study administration with clinical operations, regulatory and quality functions. The implementation emphasized electronic document management and trial master file workflows to move the organization toward a paperless clinical trial management process.
BSI CTMS was configured to deliver core Clinical Trial Management capabilities including study setup, site and subject tracking, monitoring workflow orchestration, and regulatory document control, reflecting typical CTMS functional modules. Governance changes focused on electronic approvals, audit-ready recordkeeping, and redefined project management and quality assurance procedures to support paperless workflows. The configuration and process adjustments positioned clinical operations to rely on structured CTMS processes and centralized clinical data and documentation governance.
|
Buyer Intent: Companies Evaluating BSI CTMS
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||